Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis

dc.contributor.author	Youkhana, K.
dc.contributor.author	Krishnamurthy, S.
dc.contributor.author	Williams, H.
dc.contributor.author	Tutaeva, V.
dc.contributor.author	Corbali, O.
dc.contributor.author	Kip, N.
dc.contributor.author	Metpally, R.
dc.date.accessioned	2021-03-03T16:13:46Z
dc.date.available	2021-03-03T16:13:46Z
dc.identifier.citation	Youkhana K., Tutaeva V., Williams H., Corbali O., Krishnamurthy S., Metpally R., Kip N., "Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis", 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28
dc.identifier.other	vv_1032021
dc.identifier.other	av_431b1415-d191-4bf2-b209-131fe389d2e2
dc.identifier.uri	http://hdl.handle.net/20.500.12627/48823
dc.language.iso	eng
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	ONKOLOJİ
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.title	Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis
dc.type	Bildiri
dc.contributor.department	Geisinger Medical Center , ,
dc.identifier.volume	28
dc.contributor.firstauthorID	152115

Files in this item

Files	Size	Format	View
There are no files associated with this item.